{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:46:37Z","timestamp":1787067997028,"version":"build-2736575974"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Cellular communication network factor 1 (CCN1) is a secreted matricellular protein induced by growth factors, mechanical stress, hypoxia, and tissue injury and regulates diverse cellular processes through interactions with integrins, heparan sulfate proteoglycans, and extracellular matrix (ECM) components. Although prior reviews have broadly summarized CCN1 biology, its potential as a biomarker warrants a more focused synthesis of empirical evidence. Here, we propose that CCN1 should be viewed not as a generic disease marker, but as a compartment-specific biomarker of active microenvironmental remodeling. Emerging evidence identifies CCN1 as a central regulator of bone pathology and cancer progression, functioning at the intersection of osteogenesis, osteolysis, angiogenesis, stromal remodeling, immune modulation, and metastatic colonization. Within the skeletal niche, CCN1 is produced by tumor cells, stromal fibroblasts, endothelial cells, and bone-resident cells, where it influences osteoblast and osteoclast activity and promotes vascular niche formation. CCN1 also participates in fracture repair, bone marrow mesenchymal stem cell aging, epithelial\u2013mesenchymal transition, and tumor dissemination, highlighting its roles in both regenerative and pathological processes. Importantly, CCN1 exists in distinct biological compartments, including ECM-bound, soluble circulating, extracellular vesicle-associated, and tumor cell-associated pools. These compartments likely convey different biological information, ranging from local osteogenic to systemic injury, inflammation, and metastatic spread. While circulating CCN1 is measurable and shows promise as a minimally invasive biomarker, its interpretation must account for disease context, timing, and biological compartment. We conclude that CCN1 represents a compelling translational candidate linking bone remodeling and cancer biology, with future studies needed to validate its biomarker utility in skeletal disease and metastasis.<\/jats:p>","DOI":"10.3389\/fmed.2026.1843283","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:03:44Z","timestamp":1787065424000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["CCN1 as a compartment-specific biomarker of active microenvironmental remodeling: evidence from bone repair, aging, inflammation, and cancer"],"prefix":"10.3389","volume":"13","author":[{"given":"Angela B.","family":"Tran","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, College of Health Sciences, Western University of Health Sciences","place":["Pomona, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greisha L.","family":"Ortiz-Hernandez","sequence":"additional","affiliation":[{"name":"Division of Biomarkers of Early Detection and Prevention, Department of Population Sciences, City of Hope Comprehensive Cancer Center","place":["Duarte, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"421746","DOI":"10.1155\/2015\/421746","article-title":"Biology of bone tissue: structure, function, and factors that influence bone cells.","volume":"2015","author":"Florencio-Silva","year":"2015","journal-title":"Biomed Res Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1146\/annurev.bioeng.8.061505.095721","article-title":"Biomechanical and molecular regulation of bone remodeling.","volume":"8","author":"Robling","year":"2006","journal-title":"Annu Rev Biomed Eng"},{"key":"B3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0014-5793(93)80155-n","article-title":"The modular architecture of a new family of growth regulators related to connective tissue growth factor.","volume":"327","author":"Bork","year":"1993","journal-title":"FEBS Lett"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1128\/mcb.10.7.3569-3577.1990","article-title":"Expression of cyr61, a growth factor-inducible immediate-early gene.","volume":"10","author":"O\u2019Brien","year":"1990","journal-title":"Mol Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1128\/MCB.16.4.1326","article-title":"Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion.","volume":"16","author":"Kireeva","year":"1996","journal-title":"Mol Cell Biol"},{"key":"B6","first-page":"645","article-title":"Expression of the growth factor-inducible immediate early gene cyr61 correlates with chondrogenesis during mouse embryonic development.","volume":"3","author":"O\u2019Brien","year":"1992","journal-title":"Cell Growth Differ."},{"key":"B7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1006\/excr.1997.3548","article-title":"Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development.","volume":"233","author":"Kireeva","year":"1997","journal-title":"Exp Cell Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/cells14110761","article-title":"CYR61 as a potential biomarker and target in cancer prognosis and therapies.","volume":"14","author":"Schenker","year":"2025","journal-title":"Cells"},{"key":"B9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.tibs.2008.07.006","article-title":"The CCN family of proteins: structure-function relationships.","volume":"33","author":"Holbourn","year":"2008","journal-title":"Trends Biochem Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1006\/excr.1999.4456","article-title":"The CCN family of angiogenic regulators: the integrin connection.","volume":"248","author":"Lau","year":"1999","journal-title":"Exp Cell Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1210\/edrv.20.2.0360","article-title":"The connective tissue growth factor\/cysteine-rich 61\/nephroblastoma overexpressed (CCN) family.","volume":"20","author":"Brigstock","year":"1999","journal-title":"Endocr Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/cancers13030563","article-title":"Cysteine-rich angiogenic inducer 61: pro-survival function and role as a biomarker for disseminating breast cancer cells.","volume":"13","author":"Bartkowiak","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"8991","DOI":"10.3390\/ijms26188991","article-title":"CYR61 expression is induced by IGF1 and promotes the proliferation of prostate cancer cells through the PI3\/AKT signaling pathway.","volume":"26","author":"Ortiz-Hern\u00e1ndez","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nrd3599","article-title":"Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.","volume":"10","author":"Jun","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1007\/s00018-011-0778-3","article-title":"CCN1\/CYR61: the very model of a modern matricellular protein.","volume":"68","author":"Lau","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12079-013-0193-7","article-title":"CCN proteins: a centralized communication network.","volume":"7","author":"Perbal","year":"2013","journal-title":"J Cell Commun Signal"},{"key":"B17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/clinchem\/hvab153","article-title":"Circulating cellular communication network factor 1 protein as a sensitive liquid biopsy marker for early detection of breast cancer.","volume":"68","author":"Bartkowiak","year":"2022","journal-title":"Clin Chem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12079-023-00767-6","article-title":"CCN1 is predominantly elevated in human skin dermis by solar-simulated ultraviolet irradiation and accumulated in dermal extracellular matrix.","volume":"17","author":"Qin","year":"2023","journal-title":"J Cell Commun Signal"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1359\/jbmr.2000.15.6.1014","article-title":"Temporal expression of the chondrogenic and angiogenic growth factor CYR61 during fracture repair.","volume":"15","author":"Hadjiargyrou","year":"2000","journal-title":"J Bone Miner Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/jor.20035","article-title":"CYR61 (CCN1) protein expression during fracture healing in an ovine tibial model and its relation to the mechanical fixation stability.","volume":"24","author":"Lienau","year":"2006","journal-title":"J Orthop Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"26746","DOI":"10.1074\/jbc.M705200200","article-title":"Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing.","volume":"282","author":"Athanasopoulos","year":"2007","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1101\/2024.04.05.588239","volume-title":"Cyr61 Delivery Promotes Angiogenesis During Bone Fracture Repair.","author":"Lang","year":"2024"},{"key":"B23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.matbio.2022.06.004","article-title":"Matrix-bound Cyr61\/CCN1 is required to retain the properties of the bone marrow mesenchymal stem cell niche but is depleted with aging.","volume":"111","author":"Marinkovic","year":"2022","journal-title":"Matrix Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jbmr.3394","article-title":"CYR61\/CCN1 regulates sclerostin levels and bone maintenance.","volume":"33","author":"Zhao","year":"2018","journal-title":"J Bone Miner Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.1073\/pnas.0701152104","article-title":"Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia.","volume":"104","author":"Parmar","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nature13034","article-title":"Direct measurement of local oxygen concentration in the bone marrow of live animals.","volume":"508","author":"Spencer","year":"2014","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"649387","DOI":"10.3389\/fgene.2021.649387","article-title":"CCN family proteins in cancer: insight into their structures and coordination role in tumor microenvironment.","volume":"12","author":"Jia","year":"2021","journal-title":"Front Genet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e70128","DOI":"10.1111\/cns.70128","article-title":"CCN1 promotes mesenchymal phenotype transition through activating NF-\u03baB signaling pathway regulated by S100A8 in glioma stem cells.","volume":"30","author":"Guo","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"B29","first-page":"5603","article-title":"Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies.","volume":"60","author":"Tsai","year":"2000","journal-title":"Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1677\/erc.1.00825","article-title":"Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer.","volume":"11","author":"Jiang","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"45651","DOI":"10.1074\/jbc.M301373200","article-title":"Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells.","volume":"278","author":"Kunz","year":"2003","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.onc.1208238","article-title":"A novel CYR61-triggered \u2018CYR61-alphavbeta3 integrin loop\u2019 regulates breast cancer cell survival and chemosensitivity through activation of ERK1\/ERK2 MAPK signaling pathway.","volume":"24","author":"Menendez","year":"2005","journal-title":"Oncogene"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1038\/sj.onc.1208452","article-title":"AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer.","volume":"24","author":"Vellon","year":"2005","journal-title":"Oncogene"},{"key":"B34","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/mc.20242","article-title":"A bidirectional \u201calpha(v)beta(3) integrin-ERK1\/ERK2 MAPK\u201d connection regulates the proliferation of breast cancer cells.","volume":"45","author":"Vellon","year":"2006","journal-title":"Mol Carcinog"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3389\/fonc.2019.01074","article-title":"Inhibition of CYR61-S100A4 axis limits breast cancer invasion.","volume":"9","author":"Hellinger","year":"2019","journal-title":"Front Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1242\/jcs.03460","article-title":"CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1\/2-dependent S100A4-upregulated pathway.","volume":"120","author":"Chen","year":"2007","journal-title":"J Cell Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"531","DOI":"10.21873\/cgp.20403","article-title":"Inhibition of increased invasiveness of breast cancer cells with acquired tamoxifen resistance by suppression of CYR61.","volume":"20","author":"Bauerschmitz","year":"2023","journal-title":"Cancer Genomics Proteomics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/carcin\/bgae013","article-title":"CYR61 confers chemoresistance by upregulating survivin expression in triple-negative breast cancer.","volume":"45","author":"Kim","year":"2024","journal-title":"Carcinogenesis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1308807","DOI":"10.3389\/fimmu.2023.1308807","article-title":"The prognostic implications and tumor-suppressive functions of CYR61 in estrogen receptor-positive breast cancer.","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1007\/s00264-012-1659-6","article-title":"Cysteine-rich matricellular protein improves callus regenerate in a rabbit trauma model.","volume":"36","author":"Frey","year":"2012","journal-title":"Int Orthop"},{"key":"B41","doi-asserted-by":"publisher","first-page":"eabb6351","DOI":"10.1126\/sciadv.abb6351","article-title":"Extracellular matrix compression temporally regulates microvascular angiogenesis.","volume":"6","author":"Ruehle","year":"2020","journal-title":"Sci Adv"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.1038\/srep04995","article-title":"Pancreatic tumor cell secreted CCN1\/Cyr61 promotes endothelial cell migration and aberrant neovascularization.","volume":"4","author":"Maity","year":"2014","journal-title":"Sci Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"38569","DOI":"10.1074\/jbc.M112.389064","article-title":"The matricellular protein CCN1\/Cyr61 is a critical regulator of Sonic Hedgehog in pancreatic carcinogenesis.","volume":"287","author":"Haque","year":"2012","journal-title":"J Biol Chem"},{"key":"B44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1476-4598-10-8","article-title":"Cyr61\/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis.","volume":"10","author":"Haque","year":"2011","journal-title":"Mol Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"7323","DOI":"10.1158\/0008-5472.CAN-08-0841","article-title":"CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma.","volume":"68","author":"Monnier","year":"2008","journal-title":"Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13075-019-1906-y","article-title":"Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis.","volume":"21","author":"Fan","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B47","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/jcp.2010.082768","article-title":"Expression of CTGF and Cyr61 in colorectal cancer.","volume":"64","author":"Ladwa","year":"2011","journal-title":"J Clin Pathol"},{"key":"B48","first-page":"623","article-title":"Cysteine-rich protein 61 as a novel biomarker in systemic lupus erythematosus-associated pulmonary arterial hypertension.","volume":"37","author":"Fan","year":"2019","journal-title":"Clin Exp Rheumatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"14895","DOI":"10.1073\/pnas.0401168101","article-title":"Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease.","volume":"101","author":"Ning","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B50","doi-asserted-by":"publisher","first-page":"781596","DOI":"10.3389\/fmed.2021.781596","article-title":"Serum CYR61 is associated with airway inflammation and is a potential biomarker for severity in chronic obstructive pulmonary disease.","volume":"8","author":"Tan","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1161\/01.cir.0000021426.87274.62","article-title":"Expression of CYR61, an angiogenic immediate early gene, in arteriosclerosis and its regulation by angiotensin II.","volume":"106","author":"Hilfiker","year":"2002","journal-title":"Circulation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/01.CIR.0000127952.90508.9D","article-title":"Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation.","volume":"109","author":"Hilfiker-Kleiner","year":"2004","journal-title":"Circulation"},{"key":"B53","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12079-018-0450-x","article-title":"The matricellular protein CCN1 in tissue injury repair.","volume":"12","author":"Kim","year":"2018","journal-title":"J Cell Commun Signal"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1038\/s43018-024-00854-6","article-title":"How the bone microenvironment shapes the pre-metastatic niche and metastasis.","volume":"5","author":"Jackett","year":"2024","journal-title":"Nat Cancer."},{"key":"B55","doi-asserted-by":"publisher","first-page":"437096","DOI":"10.1155\/2014\/437096","article-title":"The CCN family proteins: modulators of bone development and novel targets in bone-associated tumors.","volume":"2014","author":"Chen","year":"2014","journal-title":"Biomed Res Int"},{"key":"B56","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3390\/nu16050605","article-title":"Novel biomarkers of bone metabolism.","volume":"16","author":"Fern\u00e1ndez-Villabrille","year":"2024","journal-title":"Nutrients"},{"key":"B57","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/bonekey.2015.32","article-title":"Bone specific immunity and its impact on metastasis.","volume":"4","author":"Baschuk","year":"2015","journal-title":"Bonekey Rep"},{"key":"B58","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities.","volume":"17","author":"Ho","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: an update on therapeutic targeting strategies.","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2217\/bmm-2017-0390","article-title":"Evaluation of serum cysteine-rich protein 61 levels in patients with coronary artery disease.","volume":"12","author":"Deng","year":"2018","journal-title":"Biomark Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1093\/eurheartj\/ehx640","article-title":"Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes.","volume":"38","author":"Klingenberg","year":"2017","journal-title":"Eur Heart J"},{"key":"B62","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.4049\/jimmunol.0902792","article-title":"Matricellular protein CCN1 activates a proinflammatory genetic program in murine macrophages.","volume":"184","author":"Bai","year":"2010","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1158\/0008-5472.CAN-11-2526","article-title":"Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma.","volume":"72","author":"Haseley","year":"2012","journal-title":"Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40478-021-01124-7","article-title":"Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.","volume":"9","author":"Uneda","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"B65","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nn.4185","article-title":"The role of microglia and macrophages in glioma maintenance and progression.","volume":"19","author":"Hambardzumyan","year":"2016","journal-title":"Nat Neurosci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e2500589","DOI":"10.1002\/advs.202500589","article-title":"CCN1 enhances tumor immunosuppression through collagen-mediated chemokine secretion in pancreatic cancer.","volume":"12","author":"Fan","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B69","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer.","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B70","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1471-2407-13-154","article-title":"Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop.","volume":"13","author":"\u00d6hlund","year":"2013","journal-title":"BMC Cancer"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e46391","DOI":"10.1371\/journal.pone.0046391","article-title":"Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential.","volume":"7","author":"Salnikov","year":"2012","journal-title":"PLoS One"},{"key":"B72","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/sj.bjc.6605491","article-title":"Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.","volume":"102","author":"Ameri","year":"2010","journal-title":"Br J Cancer"},{"key":"B73","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1475-2867-3-15","article-title":"A structural approach to the role of CCN (CYR61\/CTGF\/NOV) proteins in tumourigenesis.","volume":"3","author":"Planque","year":"2003","journal-title":"Cancer Cell Int"},{"key":"B74","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00432-024-05692-8","article-title":"Chemotherapy-initiated cysteine-rich protein 61 decreases acute B-lymphoblastic leukemia chemosensitivity.","volume":"150","author":"Shi","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1002\/1878-0261.13099","article-title":"Blood-based detection of lung cancer using cysteine-rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study.","volume":"15","author":"A\u00e8kar","year":"2021","journal-title":"Mol Oncol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41568-019-0180-2","article-title":"Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells.","volume":"19","author":"Keller","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B77","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41571-019-0187-3","article-title":"Liquid biopsy and minimal residual disease - latest advances and implications for cure.","volume":"16","author":"Pantel","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.18632\/oncotarget.26986","article-title":"Cyr61\/CCN1 targets for chemosensitization in pancreatic cancer.","volume":"10","author":"Banerjee","year":"2019","journal-title":"Oncotarget"},{"key":"B79","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/1744666X.2024.2380894","article-title":"CAR-T cell technologies that interact with the tumour microenvironment in solid tumours.","volume":"20","author":"Taylor","year":"2024","journal-title":"Expert Rev Clin Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1489827","DOI":"10.3389\/fimmu.2024.1489827","article-title":"Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors.","volume":"15","author":"Khan","year":"2025","journal-title":"Front Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.2217\/nnm-2018-0094","article-title":"Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines.","volume":"13","author":"Campos","year":"2018","journal-title":"Nanomedicine (Lond)"},{"key":"B82","doi-asserted-by":"publisher","first-page":"47329","DOI":"10.1074\/jbc.M107666200","article-title":"The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts.","volume":"276","author":"Chen","year":"2001","journal-title":"J Biol Chem"},{"key":"B83","unstructured":"Ortiz\n              G\n            \n          \n          Figure 1. Cellular communication network factor 1 (CCN1) as a dynamic biomarker of microenvironmental remodeling in bone pathology and skeletal metastasis\n          \n          2026"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1843283\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:03:50Z","timestamp":1787065430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1843283\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":83,"alternative-id":["10.3389\/fmed.2026.1843283"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1843283","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"article-number":"1843283"}}